France is going to get its own corona vaccine. Sanofi and GSK, two French and British pharmaceutical companies, have been working on the issue since last year. On Monday, they said their ticker test had been successful. If all goes well, production can start from the end of this year. In that case, another name will be added to the list of vaccines in the world. The supply will also increase.
At the same time, the vaccine is going to be especially effective as a booster shot for the coroners, the French company said. The second round of the vaccine was administered to 622 volunteers in a clinical trial. It has been shown that this vaccine can strengthen the antibodies made in the body of coronavirus. Sanofi and GSK claim that the vaccine is going to be especially effective as a booster shot for those who have recovered from Corona in the coming days.
For now, however, the French company sees it as a great achievement to be able to take a place in the list of vaccines in the world. “Looking at the success of our second round of testing, we can say that this vaccine can help solve the global coronavirus crisis,” said Thomas Tramoff, Sanofi’s executive vice president. The situation at the moment is that the more ticks available, the better. However, the vaccine will also work well as a booster vaccine. “
Attempts by France to create a vaccine in 2020 failed. Experiments have shown that this vaccine is not effective on the elderly. The vaccine did not increase their immunity. However, this time the vaccine has been tested on 18-95 year olds. And tests have shown that after the second vaccine, the immune system has increased a lot. At the same time, the antibodies in the body have become 95 to 100 percent stronger, according to the study.
France is currently awaiting the third round of ticker tests. Sanofi and GSK said the vaccine would be a clinical trial on a third of the 35,000 volunteers.